UK DASA Defence Procurement Brief

Headline

UK DASA opens £1.5 million competition for innovations improving conflict wound care

Executive Summary

The UK Defence and Security Accelerator (DASA), operating within the Ministry of Defence, opened a competition on 27 January 2026 making up to £1.5 million available for innovations focused on improving medical treatment for combat-related injuries. The competition continues DASA's thematic funding model directed at filling capability gaps identified by MOD front-line commands and partner organisations, with this round targeting conflict wound care as a stated priority area for the UK Armed Forces medical services.

Key Regulatory Signals

• DASA Competition Funding Mechanism: The competition operates under DASA's standard innovation funding model, with phased proof-of-concept and demonstrator awards subject to MOD commercial assessment; eligible UK and partner-nation innovators should align proposals with DASA's scoring criteria, IP arrangements, and Defence and Security Public Contracts Regulations 2011 requirements.
• Combat Casualty Care Capability Gap: The £1.5 million conflict wound care call signals MOD focus on front-line medical capability resilience, including haemorrhage control, infection management in austere environments, and damage-control resuscitation; med-tech firms, university research groups, and defence-adjacent suppliers should evaluate proposal alignment.
• NATO Allied Joint Doctrine Alignment: UK conflict wound care innovation operates within NATO Allied Joint Doctrine 4.10 medical support framework and Allied Medical Publication standards; successful innovations may be subject to STANAG ratification processes and influence multi-national medical capability standards.
• Dual-Use Civil-Military Pathway: Many DASA-funded medical innovations have civil dual-use applications in trauma care, emergency medicine, and humanitarian medical response; firms should consider downstream MHRA medical device regulatory pathways and NHS commercial engagement alongside MOD adoption.
• UK Defence Innovation Strategy Framing: DASA competitions operationalise the UK Defence Innovation Strategy and complement the Strategic Defence Review priorities; this conflict wound care call sits within the broader UK MOD focus on front-line capability and integrated medical support, consistent with the post-Iraq/Afghanistan operational lessons-learned framework.

Regulatory Delta

DASA was established in 2016 to accelerate the introduction of innovative defence and security capabilities into UK forces and government, succeeding the Centre for Defence Enterprise. Conflict wound care has been a sustained priority of UK defence medical research since the Camp Bastion-era operational experience documented in the 2014 Joint Service Publication on combat casualty care, with subsequent programmes including the Defence Medical Services Research Strategy and Defence Science and Technology Laboratory medical workstream. This DASA competition represents a continuation of that priority, channelling innovation funding to a specific capability gap rather than a structural change in DASA's funding model or thematic focus. The action aligns with the broader UK Strategic Defence Review framework and the 2025 Defence Industrial Strategy emphasis on UK sovereign capability in critical defence-adjacent technology areas.

Materiality Classification

Moderate — Competition funding is procedural in DASA's thematic model but signals MOD priority and provides access to an established UK defence procurement pathway for innovators; downstream NHS, NATO, and MHRA implications add multi-channel value.

Time Horizon

Short-Term — Competition window standard for DASA calls (typically 8–12 weeks); proof-of-concept awards expected within 3–6 months of competition close; demonstrator phase follows on 12–24 month horizon.

Intelligence Outlook

Monitor DASA for the competition closing date, awarded innovations, and any thematic follow-on calls. Track UK Defence Medical Services and Defence Science and Technology Laboratory for resulting capability integration. Watch NATO Allied Medical Publication and STANAG processes for multinational standards convergence on UK-funded innovations.